U.S. markets closed
  • S&P 500

    +39.08 (+1.19%)
  • Dow 30

    +139.16 (+0.52%)
  • Nasdaq

    +180.72 (+1.64%)
  • Russell 2000

    +18.30 (+1.19%)
  • Crude Oil

    -0.06 (-0.17%)
  • Gold

    -0.10 (-0.01%)
  • Silver

    -0.03 (-0.15%)

    -0.0073 (-0.62%)
  • 10-Yr Bond

    +0.0540 (+6.91%)

    -0.0061 (-0.47%)

    +0.3090 (+0.30%)

    -44.17 (-0.33%)
  • CMC Crypto 200

    +22.36 (+9.21%)
  • FTSE 100

    -1.05 (-0.02%)
  • Nikkei 225

    -86.57 (-0.37%)

Global Brain PET-MRI Systems Market By Phase Type, By End User, By Product, By Region, Industry Analysis and Forecast, 2020 - 2026

·4 mins read

The Global Brain PET-MRI Systems Market size is expected to reach $406. 2 Million by 2026, rising at a market growth of 7. 8% CAGR during the forecast period. Positron outflow tomography (PET) is significantly utilized for neurological applications because of its bit benefits of giving high-resolution and 3-dimensional imaging of functional, physiologic, and molecular targets.

New York, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Brain PET-MRI Systems Market By Phase Type, By End User, By Product, By Region, Industry Analysis and Forecast, 2020 - 2026" - https://www.reportlinker.com/p05975413/?utm_source=GNW
Though it has the advantage of covering and imaging the entire brain, the pictures caught by PET innovation lacked spatial resolution, had low sensitivity, inadequate attenuation, and required to scatter correction. Hence, to beat these issues, PET devices are joined with other imaging devices essentially magnetic resonance imaging (MRI) for exact correspondence to the anatomic structures and pathologic changes.

The combination of MRI with PET is viewed as one of the best efficient hybrid imaging frameworks in the field of neurology. MRI viability in imaging the morphology of the brain and presence of MRI modalities for surveying physiologic and metabolic variables like perfusion, edema, vascular supply, and functional activation is anticipated to add to its adoption alongside PET frameworks. Hence, combined data from MRI and PET hybrid breed imaging framework assists in the upgraded diagnosis of neurological disorders. Brain PET-MRI frameworks have created new opportunities in multiparametric neuroimaging and at the same time observing the physiological and biochemical cycles of the brain. Hence, the establishment of devices in different clinical settings is expanding.

Clinical brain PET-MRI frameworks are anticipated to observe the fastest growth during the forecast period. A growing number of clinical trials for neurological issues are anticipated to add to segment development. More than 299 clinical trial investigations of brain PET-MRI frameworks for neurological disorders are presently being conducted. Also, pre-clinical brain PET-MRI frameworks are getting powerful outcomes in diagnosing neurological disorders and subsequently are entering the clinical phase. The optimistic aftereffects of these clinical trial investigations are anticipated to prompt the introduction of PET-MRI devices for neurology, which thus will upgrade the development of the overall market. Also, some significant players, for example, Siemens Healthcare has introduced the PET-MRI framework for its utilization in different clinical applications majorly neurology. Subsequently, an expanding number of clinical studies and the introduction of brain PET-MRI frameworks is anticipated to support market development.

Based on Phase Type, the market is segmented into Pre-clinical and Clinical. Based on End User, the market is segmented into Hospitals, Diagnostic imaging centers and Other End Users. Based on Product, the market is segmented into Helium-free PET/MRI Systems, Traditional PET-MRI System. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens AG (Siemens Healthineers), Koninklijke Philips N.V., General Electric (GE) Co. (GE Healthcare), Bruker Corporation, Mediso Ltd., MR Solutions Group, Cubresa, Inc. and Aspect Imaging Ltd.

Scope of the Study

Market Segmentation:

By Phase Type

• Pre-clinical

• Clinical

By End User

• Hospitals

• Diagnostic imaging centers

• Other End Users

By Product

• Helium-free PET/MRI Systems

• Traditional PET-MRI System

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific


o Brazil

o Argentina


o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Siemens AG (Siemens Healthineers)

• Koninklijke Philips N.V.

• General Electric (GE) Co. (GE Healthcare)

• Bruker Corporation

• Mediso Ltd.

• MR Solutions Group

• Cubresa, Inc.

• Aspect Imaging Ltd.

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free
Read the full report: https://www.reportlinker.com/p05975413/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001